Ekaislot specializes in designing, manufacturing, and installing packing and tray column internals, offering tailored distillation solutions for efficient separation processes.
Pressure Vessel Throughout the entire manufacturing process, we adhere to stringent quality control procedures. Our pressure vessels are capable of withstanding extremely high internal and external pressures and are suitable for a wide variety of application scenarios.
Ekaislot is ISO9001 certified and ASME authorized, ensuring that all products comply with international standards for quality and safety. All products are covered by our strict quality control methodology.
SpaciousFacilities
Ekaislot operates extensive facilities totaling 8600 m² for processing, 3000 m² for clean production, and 1200 m² for office space in Shanghai and Nantong, supporting high-quality manufacturing.
OUR STRENGTHS
ExpertTechnical Background
With over 12 years of experience, Ekaislot specializes in developing column and reactor internals and holds multiple patents to enhance the efficiency of distillation columns and separators.
ComprehensiveService and Support
The company provides complete solutions, including on-site installation and robust after-sales support, ensuring the efficient and reliable performance of reactor internals, distillation columns and filters in real-world applications.
The text focuses on the quality control and regulatory framework for continuous flow pharmaceuticals. The ICH Q13 guidelines have core requirements including batch definition adaptable to market demands, Process Analytical Technology for online parameter monitoring, and equipment validation for over 100 - hour continuous operation. A typical case is the continuous synthesis of tetrazoles with optimization strategies to increase yield and ensure process safety. There are technical challenges such as reaction system compatibility, equipment congestion and high maintenance costs, and regulatory lag. Solutions involve modular design, innovative materials, clean - in - place systems, FDA's CQA database, and industry collaboration. Future trends include intelligent integration with AI, expansion of green chemistry, biopharmaceutical fusion, and the development of modular factories.
Continuous Flow Technology (CFT) achieves chemical reaction process continuity via equipment like microchannel reactors and fixed beds. Its core advantages are process intensification and precise control, different from traditional batch production. Continuous flow microreactors can solve user pain - points, including increased safety, efficiency breakthrough, consistent quality, and green manufacturing. In pharmaceutical production, CFT can be classified according to reaction systems: gas - liquid reaction system (e.g., carbonylation reactions with a tube - in - tube device for mixing), solid - liquid reaction system (e.g., palladium - catalyzed Suzuki coupling with a long - life catalyst in a fixed - bed reactor), gas - liquid - solid reaction system (e.g., continuous hydrogenation with integrated water electrolysis hydrogen production and extended to deuterated drug synthesis), liquid - liquid reaction system (e.g., Bucherer - Bergs reaction with high - pressure intensification), and multi - phase integrated system (e.g., SPS - FLOW system for automated production of Prexasertib and synthesis of tetrazoloid derivatives).
Continuous flow technology has significant advantages but faces challenges like high equipment investment and solid - liquid system clogging in the new materials industry. Continuous flow microreactors offer intelligent integration with PID precise process control and multi - level linkage control, a disc shear flow channel for high - speed shear flow and efficient mass and heat transfer in gas - liquid - solid three - phase reactions, and modular design with industrial - grade skid - mounted features that save floor space and enable full - process automation. Continuous flow technology and microreactors are driving the new materials industry towards efficiency, greenness and customization, covering key fields such as electronics, energy and environmental protection. It's expected that by 2030, continuous flow technology will take over 50% of the market share of the new materials' core process.
Continuous flow technology and microreactors are revolutionizing the new materials industry. Their technical advantages include efficient mass and heat transfer, precise process control and intrinsic safety. The micron - scale channel design of microreactors provides a much higher specific surface area than traditional reactors, improving reaction rate and selectivity. Continuous flow technology allows seamless scale - up from lab to industrial production, shortening new product development cycles. Core application scenarios include: in bio - based material synthesis, it solves traditional process problems and enables mass production of high - purity products; in high - performance polymer development, it enhances product properties and reduces costs; in nanomaterials and electronic chemicals, it enables precise synthesis and improves product performance; in green energy materials, it helps develop new battery materials and reduces catalyst costs.